MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1073/pnas.2119804119

Медицинская библиотека · Proceedings of the National Academy of Sciences of the United States of America · 2022

Signatures of glial activity can be detected in the CSF proteome.

Eninger Timo, Müller Stephan A, Bacioglu Mehtap, Schweighauser Manuel, Lambert Marius, Maia Luis F, Neher Jonas J, Hornfeck Sarah M, Obermüller Ulrike, Kleinberger Gernot, Haass Christian, Kahle Philipp J, Staufenbiel Matthias, Ping Lingyan, Duong Duc M, Levey Allan I, Seyfried Nicholas T, Lichtenthaler Stefan F, Jucker Mathias, Kaeser Stephan A

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Single-cell transcriptomics has revealed specific glial activation states associated with the pathogenesis of neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease. While these findings may eventually lead to new therapeutic opportunities, little is known about how these glial responses are reflected by biomarker changes in bodily fluids. Such knowledge, however, appears crucial for patient stratification, as well as monitoring disease progression and treatment responses in clinical trials. Here, we took advantage of well-described mouse models of β-amyloidosis and α-synucleinopathy to explore cerebrospinal fluid (CSF) proteome changes related to their respective proteopathic lesions. Nontargeted liquid chromatography-mass spectrometry revealed that the majority of proteins that undergo age-related changes in CSF of either mouse model were linked to microglia and astrocytes. Specifically, we identified a panel of more than 20 glial-derived proteins that were increased in CSF of aged β-amyloid precursor protein- and α-synuclein-transgenic mice and largely overlap with previously described disease-associated glial genes identified by single-cell transcriptomics. Our results also show that enhanced shedding is responsible for the increase of several of the identified glial CSF proteins as exemplified for TREM2. Notably, the vast majority of these proteins can also be quantified in human CSF and reveal changes in Alzheimer’s disease cohorts. The finding that cellular transcriptome changes translate into corresponding changes of CSF proteins is of clinical relevance, supporting efforts to identify fluid biomarkers that reflect the various functional states of glial responses in cerebral proteopathies, such as Alzheimer’s and Parkinson’s disease.

Для цитирования: Eninger Timo, Müller Stephan A, Bacioglu Mehtap, Schweighauser Manuel, Lambert Marius, Maia Luis F, Neher Jonas J, Hornfeck Sarah M, Obermüller Ulrike, Kleinberger Gernot, Haass Christian, Kahle Philipp J, Staufenbiel Matthias, Ping Lingyan, Duong Duc M, Levey Allan I, Seyfried Nicholas T, Lichtenthaler Stefan F, Jucker Mathias, Kaeser Stephan A. Signatures of glial activity can be detected in the CSF proteome.. Proceedings of the National Academy of Sciences of the United States of America. 2022. DOI: 10.1073/pnas.2119804119.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.